Overview

Clear-cell sarcoma is an uncommon malignant tumor of soft tissues that shows features similar to melanocytic tumors. It most often arises in deep dermis, subcutis or in association with tendons and aponeuroses of the extremities. It is classified among sarcomas and represents a distinct clinical and molecular entity within soft‑tissue neoplasms. Because it is a form of cancer, management typically involves specialist surgical and oncologic input.

Clinical and pathological characteristics

Patients are usually adolescents or young adults, though the tumor can occur at other ages. Clinically it presents as a slow‑growing, painful or painless mass. Pathology shows nests or fascicles of spindle to epithelioid cells with clear or pale cytoplasm. Immunohistochemistry commonly demonstrates positivity for melanocytic markers such as S100, HMB45 and Melan-A. A characteristic chromosomal rearrangement—most often an EWSR1‑ATF1 fusion, and sometimes EWSR1‑CREB1—is considered a diagnostic hallmark.

Diagnosis

Diagnosis combines imaging, histology, immunostaining and molecular testing. Imaging (MRI or CT) defines local extent. Definitive diagnosis frequently depends on demonstration of the gene fusion by molecular techniques. Distinction from cutaneous melanoma and other soft‑tissue tumors is important for correct management.

Treatment and prognosis

Treatment is primarily surgical: wide local excision with clear margins is the mainstay. Management may include:

  • wide excision and, when indicated, limb-sparing techniques
  • sentinel lymph node assessment because of a propensity for lymphatic spread
  • adjuvant radiotherapy for local control; systemic chemotherapy has limited benefit

Local recurrence and distant metastasis (commonly to lymph nodes and lungs) are relatively frequent. Long‑term follow‑up is necessary due to risk of late recurrence.

History and notable distinctions

Historically this tumor was once called "malignant melanoma of soft parts" because of its melanocytic appearance, but molecular profiling established it as a separate sarcoma. It is important not to confuse clear‑cell sarcoma of soft tissue with pediatric clear cell sarcoma of the kidney, which is a distinct renal neoplasm with different behavior and genetics.

Because of its rarity, care of patients with clear‑cell sarcoma is usually coordinated through specialized centers or multidisciplinary sarcoma teams, and enrollment in clinical studies is often considered when available.